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Does the conditioned medium trigger 
the adipose-derived mesenchymal stem 
cells differentiation into Chondrocytes? 
ABSTRACT
Background: Cartilage is an avascular tissue that has limited regenerative capacity. Stem cells, especially 
mesenchymal stem cells (MSCs), have been regarded as a promising cell source for cartilage repair due 
to their multi-lineage differentiation potential. Induction of mesenchymal stem cells into functional chon-
drocytes may resolve the above problems in the cartilage repair. However, the imperative is to develop 
effective strategies for chondrogenic differentiation. The aim of this study is to evaluate if the induction of 
adipose-derived mesenchymal stem cells (ADSCs) differentiation toward chondrocytes is possible with 
the use of conditioned medium derived from chondrocytes culture.
Material and methods: Conditioned medium (CM) from Normal chondrocyte cell line CRL 2648 was used to culture 
ADSCs, at the same time ADSCs with standard growth medium were used as a control. During this experiment, the 
phenotype was assessed using flow cytometry (CD90, CD44, CD45 and CD45), and Immunohistochemical 
staining was used to determine differentiation (anti-aggrecan, anti-CD15, anti-collagen II, anti-TRA-2-49). 
Results: ADSCs propagated rapidly in vitro and formed a homogenous fibroblast-like morphology. 0% of tested 
cells showed the expression of CD90 and CD44, while more than 90% did not reveal the expression of 
CD34 and CD45. Results obtained in this study showed weak cytoplasmatic expression of aggrecan 
and alkaline phosphatase (TRA protein) and lack of CD151 expression. However, the majority of ADSCs 
expanded with CM expressed type II collagen indicating that the chondrocyte-secreted factors induced 
chondrogenic commitment during expansion.
Conclusions: In the natural environment of living organisms, the chondrogenic differentiation of stem cells in-
volve multiple signalling pathways. We can, to an extent mimic these signals in vitro however, for the clinical 
purposes it is very important to develop well-defined and efficient in vitro protocols. Our results indicate 
that CM may regulate and induce differentiation of ADSCs into the chondrocyte lineage and can serve 
also as an in vitro model for studying specific lineage commitment.
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Introduction
Traumatic injury and age-related degenerative dis-
eases associated with cartilage are major health prob-
lems occurring worldwide [1, 2]. Cartilage is an avas-
cular tissue that has limited regenerative capacity [3]. 
However, transplantation of autologous chondrocytes 
is widely utilized in clinical practice and has reached 
broad acceptance [4, 5]. Nevertheless, this treatment is 
limited due to only filling small defects, de-differentiation 
of chondrocytes during in vitro culture or loss of colla-
gen II content [5]. Stem cells, especially mesenchymal 
stem cells (MSCs), have been regarded as a promising 
cell source for cartilage repair due to their multi-lineage 
differentiation potential [6–8]. Furthermore, significant 
progress has been made in the field of regenerative 
medicine with the use of mesenchymal stem cells [9]. 
Induction of mesenchymal stem cells into functional 
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chondrocytes may resolve the above problems in the 
cartilage repair. However, the imperative is to develop 
efficient strategies for chondrogenic differentiation. 
Many factors can induce MSCs into chondrocytes, 
especially growth factors, signal factors and proper 
microenvironment [6, 10, 11]. Previous studies have 
investigated that chondrocyte-secreted factors may 
influence the mesenchymal stem cells via paracrine, 
juxtracrine or gap-junction signalling pathways [6, 12]. 
The aim of this study is to evaluate if the induction of 
adipose-derived mesenchymal stem cells (ADSCs) differ-
entiation toward chondrocytes is possible with the use of 
conditioned medium derived from chondrocytes culture.
Material and methods
Chondrocyte culture and conditioned medium
Normal chondrocyte cell line CRL 2648 (ATCC, USA) 
were cultured using DMEM/Ham’s F12 supplemented 
with 10% FBS, 5μg/ml amphotericin B and 100μg/ml 
penicillin/streptomycin. The conditioned medium (CM) 
was harvested every two days, filtered using a syringe 
filter (0.22μm) and stored at -20°C until use.
Isolation and cultivation of ADSCs
The Local Bioethical Committee of Nicolaus Coper-
nicus University approved all procedures. Rat ADSCs 
were obtained from abdominal adipose tissue and 
washed in PBS with antibiotics: penicillin/streptomy-
cin (100 μg/ml) and amphotericin B (5 μg/ml). Then, 
tissue was purified from blood vessels and incubated 
in Collagenase I solution (1ml/g of tissue) (Sigma, Ger-
many) for 30 min at 37°C with shaking in every 5 min. 
Digestion process was inhibited by adding an equal 
volume of culture medium. After that, tissue was filtrated 
using a 100μm cell strainer (BD Bioscience, USA). The 
obtained filtrate was centrifuged 350xg for 10 min and 
the cell pellet was washed twice with culture medium. 
Cells were cultured in DMEM/Ham’s F12 supplemented 
with 10% FBS (PAA, Austria), 10ng bFGF (Sigma, Ger-
many), amphotericin B (5μg/ml), penicillin/streptomycin 
(100μg/ml) and L-glutamine (PAA, Austria).
ADSCs phenotype analysis
The phenotype of adipose-derived mesenchymal 
stem cells was confirmed by examining markers ex-
pression (BD Bioscience, USA) with the use of flow 
cytometry (Tab. 1).
Briefly, cells were resuspended at a density 
1x106 cells/ml in cold PBS containing antibodies accord-
ing to Table 1. Cells with antibodies were then incubated 
for 30 min in 4°C in the dark. After incubation, cells were 
washed three times with PBS and centrifuged at 350xg 
by 5 min. Flow cytometry analysis was performed on 
EPICS XL using System 2 Software version 3.0 (Beck-
man-Coulter, Miami FL, USA). 
Induction of differentiation
Pellets of 3x105 ADSCs, after 3rd passage, were 
formed by centrifugation at 350xg by 5 min in 15 ml 
sterile falcons (BD Bioscience, USA). After 24 hours of 
pre-incubation, the basic medium was removed and 
ADSCs were subcultivated for 14 days in CM obtained 
from a culture of normal chondrocyte cell line. Then, 
pellets were fixed with 10% buffered paraformaldehyde 
and analyzed by immunohistochemical. Cells cultured 
in a basic culture medium served as a control. 
Immunohistochemical staining as 
a detection tool for differentiation
Immunohistochemical reaction was performed on 
the cytological material in the form of paraffin cell-blocks 
with a slice thickness of 3 μm. Immunohistochemical 
studies were performed using primary antibodies (Mil-
lipore, USA) according to Table 2. 
For identification of formed antigen-specific antibody 
complex, EnVision Anti-Mouse HRP was used (DAKO). 
Localization of the aforementioned complexes was visu-
alized by 3-3’diaminobenzidine (DAB) as the chromogen.
RESULTS
Characteristic of adipose-derived mesenchymal 
stem cells
ADSCs propagated rapidly in vitro and formed a ho-
mogenous fibroblast-like morphology. For phenotypic 
characterization, ADSCs after the 3rd passage was as-
sessed in expression levels of CD90, CD34, CD45 and 
CD44. 70% of tested cells showed the expression of 
CD90 and CD44, while more than 90% did not reveal 
the expression of CD34 and CD45 (Fig.1). Such results 
indicate the mesenchymal nature of isolated cells.
Table 1. Markers used in flow cytometry
Marker Concentration Cell localization
CD90 20μl/test Cell membrane
CD44 20μl/test Cell membrane
CD34 5μl/test Cell membrane
CD45 5μl/test Cell membrane
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Table 2. Markers used in immunohistochemistry
Marker Concentration Time of incubation
Anti-aggrecan (AB1031) 1:100 30  min 37°C
Anti-CD151 (MABT58) 1:100 16 hours 4°C
Anti-collagen II (JBC1778630) 1:100 16 hours 4°C
Anti-TRA-2-49 (MAB4349) 1:100 30 min 37°C
Figure 1. Expression of CD90, CD44, CD34 and CD45 on the surface of ADSCs
Effect of Conditioned Medium on differentiation 
induction of ADSCs toward chondrocytes
The initial goal of this study was to determine the 
chondrogenic commitment of ADSCs in vitro. After 
14 days of CM expansion, the chondrocyte differentiation 
of adipose-derived mesenchymal stem cells was investi-
gated by immunostaining for type II collagen, aggrecan, 
CD151 and alkaline phosphatase. Results obtained in 
this study showed weak cytoplasmatic expression of 
aggrecan and alkaline phosphatase (TRA protein) and 
lack of CD151 expression. However, the majority of 
ADSCs expanded with CM expressed type II collagen 
indicating that the chondrocyte-secreted factors induced 
chondrogenic commitment during expansion (Fig.2).
DISCUSSION
In attempting to use stem cells for cartilage repair, 
it is imperative to develop well-defined and efficient 
protocols for directing stem cell differentiation into the 
chondrogenic lineage in vitro [1, 2]. Such pre-differen-
tiation in vitro can reduce spontaneous differentiation of 
stem cells, which are defined as an undifferentiated, in 
vivo. Moreover, it will result in higher efficiency of trans-
plantation and better integration with recipient tissue. 
Adult stem cells derived from adipose tissue and bone 
marrow have shown significant chondrogenic potential 
[7, 11]. However, adipose-derived mesenchymal stem 
cells still remain less well characterized. It is very difficult 
to elucidate the molecular mechanisms and signalling 
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Figure 2. Effects of chondrocyte-conditioned medium (CM) on ADSCs
pathways that regulate chondrogenesis in vivo, within an 
animal model. There are different experimental models 
for directing the chondrogenic differentiation of stem 
cells in vitro, inter alia well-defined culture medium, 
using of exogenous cytokines and growth factors, 
co-culture with chondrocyte or genetic manipulation 
[1]. One of the current approaches includes the use of 
conditioned media obtained from the culture of normal 
chondrocytes. That is why the aim of our study was to 
evaluate if the CM harvested from the normal chondro-
cyte cell line is a sufficient factor for induction ADSCs 
differentiation toward chondrocyte phenotype. Previous 
studies have shown that culture media conditioned 
by embryonic calvarial cells, embryonic limb bud and 
perichondrial cells have stimulatory effects on chon-
drogenesis [13–15]. Liu et al reported that conditioned 
medium derived from chondrocyte/scaffold constructs 
induced the bone marrow mesenchymal stem cells 
differentiation after 4 weeks [16]. Immunohistochemical 
analysis in our studies revealed the positive staining of 
collagen II, aggrecan even after 2 weeks of differenti-
ation conditions. Within cartilaginous tissue, the major 
collagen is collagen type II, whereas the predominant 
proteoglycan is aggrecan [1, 8]. Expression of these 
specific for cartilage markers indicates on induction of 
differentiation process [16]. Weiss et al also defined 
the chondrogenic differentiation of mesenchymal stem 
cells as a successful when collagen type II and proteo-
glycans were detected [4]. Hwang et al gained similar 
results. However, they also noticed the expression of 
collagen I and X, which can suggest the hypertrophy 
of cells [5]. We noticed the weak expression of alkaline 
phosphate also, although we did not see the decrease 
in the synthesis of collagen type II. We did not reveal 
the presence of CD151, which is a surface marker of 
chondrocytes. However, this marker is often tested 
in monolayer culture of chondrocytes, its expression 
can be much less prevalent in pellet culture [17]. Re-
cently, some studies revealed that chondrocytes are 
capable of producing and releasing numerous growth 
factors and cytokines, including bone morphogenetic 
protein-2 (BMP-2), parathyroid hormone (PTH) and 
TGF-b1 [16, 18, 19, 20, 21]. It is quite probable that 
they are likely to present in the chondrocyte CM utilized 
in our study. Nevertheless, we did not make such an 
evaluation. Liu et al. tested the growth factors present in 
the CM derived from human coastal chondrocytes/scaf-
folds constructs by protein microassay and the CM 
contained low levels of TGF- b1,2,3, IGF-1 and high 
levels of IGF-2, FGF-4 and IGFBP4 [4]. It can explain 
the induction of chondrogenic differentiation of ADSCs, 
which was revealed in our study. It seems that chon-
drocyte-secreted factors may be one strategy to in vivo 
engineer cartilage tissue. Liu et al. also indicated these 
proteins as agents playing an important role in this 
process [22]. Although, the exact mechanism of how 
the soluble factors promote chondrogenic differentiation 
of stem cells is still unclear. The challenge is also to 
find an optimized combination of these factors for the 
promotion of chondrocyte differentiation. It is worth 
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noting that the concentration of the aforementioned 
proteins in the CM is probably much lower than those 
used for conventional chondrogenic induction [23], but 
still, the induction of differentiation was possible. The 
pellet culture also allows physiological 3D cell-cell and 
cell-matrix interaction [4, 24]. Due to that, all cells may 
sense the inductive signals from the CM at the same 
time even without properly prepared matrix architecture. 
Our immunohistochemical analysis of collagen II 
and aggrecan support the claim that the chondrocyte 
CM can be utilized for the efficient cartilaginous tissue 
formation by ADSCs in vivo. Nevertheless, it is important 
to note that the use of filtered CM does not alleviate the 
risk of viral transmission. Also, secreted factors within 
conditioned media may be labile and not suitable for 
prolonged durations of in vitro culture [1]. That is why 
there is a need to further investigate the morphogenetic 
factors responsible for chondrogenic priming of ADSCs. 
CONCLUSIONS
Despite a large number of studies, the chondrogenic 
differentiation of stem cells in vitro still requires clarifi-
cation. In the natural environment of living organisms, 
the chondrogenic differentiation of stem cells involves 
multiple signalling pathways. We can, to an extent 
mimic these signals in vitro however, for the clinical 
purposes it is very important to develop well-defined 
and efficient in vitro protocols. Our results indicate that 
CM may regulate and induce differentiation of ADSCs 
into the chondrocyte lineage and can serve also as an 
in vitro model for studying specific lineage commitment.
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